Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 1;26(49):11129-11134.
doi: 10.1002/chem.202001613. Epub 2020 Jul 28.

Fluorescent Arylphosphonic Acids: Synergic Interactions between Bone and the Fluorescent Core

Affiliations

Fluorescent Arylphosphonic Acids: Synergic Interactions between Bone and the Fluorescent Core

Yunus Zorlu et al. Chemistry. .

Abstract

Herein, we report the third generation of fluorescent probes (arylphosphonic acids) to target calcifications, particularly hydroxyapatite (HAP). In this study, we use highly conjugated porphyrin-based arylphosphonic acids and their diesters, namely 5,10,15,20-tetrakis[m-(diethoxyphosphoryl)phenyl]porphyrin (m-H8 TPPA-OEt8 ) and 5,10,15,20-tetrakis [m-phenylphosphonic acid]porphyrin (m-H8 TPPA), in comparison with their positional isomers 5,10,15,20-tetrakis[p-(diisopropoxyphosphoryl)phenyl]porphyrin (p-H8 TPPA-iPr8 ) and 5,10,15,20-tetrakis [p-phenylphosphonic acid]porphyrin (p-H8 TPPA), which have phosphonic acid units bonded to sp2 carbon atoms of the fluorescent core. The conjugation of the fluorescent core is thus extended to the (HAP) through sp2 -bonded -PO3 H2 units, which generates increased fluorescence upon HAP binding. The resulting fluorescent probes are highly sensitive towards the HAP in rat bone sections. The designed probes are readily taken up by cells. Due to the lower reported toxicity of (p-H8 TPPA), these probes could find applications in monitoring bone resorption or adsorption, or imaging vascular or soft tissue calcifications for breast cancer diagnosis etc.

Keywords: Alzheimer's disease; calcifications; fluorescent imaging; ligand synthesis; vascular calcifications.

PubMed Disclaimer

Conflict of interest statement

G.Y. and H.H. have pending patent protecting some of the presented data.

Figures

Scheme 1
Scheme 1
The fluorescent probes used in this study: A) 5,10,15,20‐Tetrakis[p‐(diisopropoxyphosphoryl)phenyl]porphyrin (p ‐H8TPPA‐iPr8). B) 5,10,15,20‐Tetrakis [p‐phenylphosphonic acid]porphyrin (p ‐H8TPPA). C) 5,10,15,20‐Tetrakis[m‐(diethoxyphosphoryl)phenyl]porphyrin (m ‐H8TPPA‐OEt8). D) 5,10,15,20‐Tetrakis [m‐phenylphosphonic acid]porphyrin (m ‐H8TPPA).
Figure 1
Figure 1
Mouse ribs incubated with either p ‐H8TPPA (λ ex/em 595/613 nm; exposure time −200 ms) or m ‐H8TPPA (λ ex/em 578/603 nm; exposure time −100 ms) diluted to 1 mg mL−1 in HEPES (A–E or F–J, respectively) and counter‐stained with DAPI (λ ex/em 359/461 nm; exposure time: −200 or 100 ms, respectively). Images were captured on the day of staining (A and F), as well as after 4 days (B and G), 7 days (C and H), and 14 days (D and I). A negative control of mouse ribs incubated with each buffer alone is also included (E and J, respectively). Scale bar=100 μm.
Figure 2
Figure 2
The absorbance (A) and fluorescence (B) spectra of 0.01 mg mL−1 p ‐H8TPPA in the presence (dashed lines) and absence (solid lines) of HAP. The dye was diluted to 0.01 mg mL−1 in PBS (pH 7.4, green), TBS (pH 7.4, orange), HEPES (pH 7.4, purple) and d H2O with absorbance and fluorescence spectra obtained using the Flexstation 3 microplate reader.
Figure 3
Figure 3
Fluorescence spectra of THP‐1 monocytes cells incubated with p ‐H8TPPA.

References

    1. Vallejo-Illarramendi A., Toral-Ojeda I., Aldanondo G., López de Munain A., Expert. Rev. Mol. Med. 2014, 16, E16. - PubMed
    1. “Soft Tissue Calcification and Ossification”: Newberg A. H. in Imaging of Arthritis and Metabolic Bone Disease (Ed.: B. N. Weissman), Elsevier, 2009, chap. 39, pp. 681–696.
    1. Ramos E. M., Oliveira J., Sobrido M. J., Cappola G., Primary Familial Brain Calcification (Eds.: M. P. Adam, H. H. Ardinger, R. A. Pagon, S. E. Wallace, L. J. H. Bean, K. Stephens, A. Amemiya) 2004, Apr 18 [Updated 2017 Aug 24]. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020.
    1. Pilgrim M. G., Lengyel I., Lanzirotti A., Newville M., Fearn S., Emri E., Knowles J. C., Messinger J. D., Read R. W., Guidry C., Curcio C. A., Invest. Ophthalmol. Vis. Sci. 2017, 58, 708–719. - PMC - PubMed
    1. Moe S. M., Chen N. X., J. Am. Soc. Nephrol. 2008, 19, 213–216. - PubMed

LinkOut - more resources